behavior/neurological
• mutants are insensitive to the ataxic, sedative, and analgesic effects of a hypnotic drug, gaboxadol
• mutant mice do not display ataxia induced by 10 mg/kg gaboxadol (GBX) and show greatly reduced ataxic response to 15 mg/kg GBX compared to wild-type mice
• treatment with GBX has no significant effect on total locomotor activity in Gabra4-null mice whereas wild-type mice show significantly reduced locomotor activity in response to GBX
|
• after GBX treatment, mutant mice show a slight but significant increase in tail-flick latency compared to baseline, while wild-type mice exhibit a markedly prolonged latency to tail flick compared to baseline
|
nervous system
• treatment of hippocampal slices with GABA uptake inhibitor results in concentration-dependent increases in holding current in wild-type, but not mutant preparations
• subsequent application of picrotoxin reduces holding current in wild-type and mutant dentate granule cells (DGCs); this picrotoxin-sensitive, tonic current (Itonic) is reduced greatly in mutant DGCs
• in ventrobasal thalamic neurons, tonic currents in mutant neurons are not affected by GBX which evokes large inward currents in wild-type neurons; effects of SR95531 and GBX are absent or greatly reduced in mutant neurons compared to wild-type responses
|
• examination of miniature IPSC kinetics under basal conditions reveals marked slowing of the rise and early decay of mIPSCs in mutant DGCs
|